Stepwise Targeted Screening for Familial Hypercholesterolemia in a Resource-Limited Setting: A Scalable Model Linking Premature Coronary Artery Disease and Community Screening in Vietnam
References
- Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478–3490a. DOI: 10.1093/eurheartj/eht273
- Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng MJ, et al. Comparative aspects of the care of familial hypercholesterolemia in the ‘Ten Countries Study’. J Clin Lipidol. 2019;13(2):287–300. DOI: 10.1016/j.jacl.2019.01.009
- Pang J, Hu M, Lin J, Miida T, Nawawi HM, Park JE, et al. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: The ‘Ten Countries Study’. BMJ Open. 2017;7(10):
e017817 . DOI: 10.1136/bmjopen-2017-017817 - Representatives of the Global Familial Hypercholesterolemia Community, Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, et al. Reducing the clinical and public health burden of familial hypercholesterolemia: A global call to action. JAMA Cardiol. 2020;5(2):217–229. DOI: 10.1001/jamacardio.2019.5173
- Macholdt E, Arias L, Duong NT, Ton ND, Van Phong N, Schröder R, et al. The paternal and maternal genetic history of Vietnamese populations. Eur J Hum Genet. 2020;28:636–645. DOI: 10.1038/s41431-019-0557-4
- Truong TH, Do DL, Kim NT, Nguyen MT, Le TT, Le HA. Genetics, screening, and treatment of familial hypercholesterolemia: Experience gained from the implementation of the Vietnam familial hypercholesterolemia registry. Front Genet. 2020;11:914. DOI: 10.3389/fgene.2020.00914
- Qureshi N, Da Silva MLR, Abdul-Hamid H, Weng SF, Kai J, Leonardi-Bee J. Strategies for screening for familial hypercholesterolaemia in primary care and other community settings. Cochrane Database Syst Rev. 2021;10(10):CD012985. DOI: 10.1002/14651858.cd012985.pub2
- Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, et al. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: Evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316(6):645–655. DOI: 10.1001/jama.2016.6176
- Watts GF, Gidding SS, Hegele RA, Raal FJ, Sturm AC, Jones LK, et al. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol. 2023;20(12):845–869. DOI: 10.1038/s41569-023-00892-0
- Hu P, Dharmayat KI, Stevens CAT, Sharabiani MTA, Jones RS, Watts GF, et al. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: A systematic review and meta-analysis. Circulation. 2020;141(22):1742–1759. DOI: 10.1161/circulationaha.119.044795
- Nguyen KM, Hoang SV. Prevalence of genetically diagnosed familial hypercholesterolemia in Vietnamese patients with premature acute myocardial infarction. Med (Baltim). 2024;103(39):
e39939 . DOI: 10.1097/md.0000000000039939 - Lin EH, Feingold CL, Yazditabar JM, Subhash AK, Panoussi E, Liu JN. Comparison of outcomes in retrospective vs. prospective Latarjet studies for shoulder instability. JSES Rev Rep Tech. 2025;5(4):899–903. DOI: 10.1016/j.xrrt.2025.07.005
- Jokiniitty A, Eskola M, Saarela T, Huhtala H, Metso S. Role of an automated screening tool for familial hypercholesterolemia in patients with premature coronary artery disease. Atheroscler Plus. 2022;48(22):1–7. DOI: 10.1016/j.athplu.2022.01.001
- Knowles JW, Rader DJ, Khoury MJ. Cascade screening for familial hypercholesterolemia and the use of genetic testing. JAMA. 2017;318(4):381–382. DOI: 10.1001/jama.2017.8543
- Soukup J, Zierhut HA, Ison HE, UMN Genetic Counseling Program Class of 2020. Universal cholesterol screening among pediatric primary care providers within California and Minnesota: A qualitative assessment of barriers and facilitators. J Pediatr. 2021;233:175–182.e2. DOI: 10.1016/j.jpeds.2021.02.065
- Marquina C, Morton JI, Lloyd M, Abushanab D, Baek Y, Abebe T, et al. Cost-effectiveness of screening strategies for familial hypercholesterolaemia: An updated systematic review. Pharmacoeconomics. 2024;42(4):373–392. DOI: 10.1007/s40273-023-01347-7
- Meng R, Shi F, Zhang B, Li C, Wang J, Song L, et al. Cost-effectiveness of universal genetic screening for familial hypercholesterolemia in young adults aged 18–40 years in China. BMC Med. 2025;23(1):139. DOI: 10.1186/s12916-025-03966-7
DOI: https://doi.org/10.5334/gh.1557 | Journal eISSN: 2211-8179
Language: English
Page range: 40 - 40
Submitted on: Feb 16, 2026
Accepted on: May 5, 2026
Published on: May 18, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2026 Thanh-Huong Truong, Doan-Loi Do, Minh-Phuong Vu, Mai-Ngoc Thi Nguyen, Hong-An Le, Thanh-Tung Le, Trung-Thanh Tran, Hong-Phu Vu, Dinh-Tuan Nguyen, Van-Dung Le, Ngoc-Thanh Kim, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.